IP30: Bladder Cancer: Upper Tract Transitional Cell Carcinoma I
Saturday, May 16, 2026 7:00 AM to 9:00 AM · 2 hr. (America/New_York)
147B
Poster and Podium Sessions
Oncology: Bladder
Saturday, May 16
IP30-05: Diagnostic Yield of Ureteroscopic Biopsy for Upper Tract Urothelial Cancer is Improved with Microbiopsy
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-01: Whole Exome Sequencing Of Urinary Cytology from Upper Tract Urothelial Carcinoma Demonstrates Genomic Concordance Independent of Cytology Result
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-02: URINE-DERIVED TUMOR DNA (utDNA) OUTPERFORMS PLASMA CELL-FREE DNA (ctDNA) IN PROFILING THE GENOMIC LANDSCAPE OF UTUC
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-03: Long-Term Follow-Up Results of aMVAC Arm of ECOG-ACRIN EA8141: a Prospective Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery for Patients with High-Grade Upper Tract Urothelial Carcinoma
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-04: The ENLIGHTED Phase 3 Trial: Advancing Treatment of Low-Grade Upper Tract Urothelial Carcinoma (LG UTUC) with Padeliporfin Vascular-Targeted Photodynamic Therapy (VTP)
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-06: Longitudinal urine-tumor DNA Dynamics Predict Recurrence Risk in Upper Tract Urothelial Carcinoma: A Prospective Cohort Study
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
ZUO WEI · Peking University First Hospital
IP30-07: Impact of Surgical Delay on Outcomes in High-Risk Upper Tract Urothelial Carcinoma: Insights from the ROBUUST 3.0 Collaborative
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
Luca Lambertini · Careggi
IP30-08: Use of Duplex-Seq in the Genomic Characterization of Lynch Syndrome patients with Upper Tract Urothelial Carcinoma
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-09: Impact of adjuvant intracavitary therapy on recurrence of upper tract urothelial carcinoma following endoscopic management
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-10: Venous Tumor Thrombus Should Be Added to Clinical and Pathology T4 Staging Criteria in Upper Tract Urothelial Carcinoma
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-11: Histological Evaluation of Tertiary Lymphoid Structures Predicts Prognosis in Upper Tract Urothelial Carcinoma: A Cox-Based Nomogram Analysis
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-12: Evaluating deep early tumor shrinkage in metastatic upper tract urothelial carcinoma treated with enfortumab vedotin plus pembrolizumab
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-13: Prognostic Value of HDAC4 Expression in Upper Tract and Bladder Urothelial Carcinoma
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-14: Application of transcriptomic bladder-cancer subtypes to upper-tract urothelial carcinoma (UTUC) across international cohorts reveals racial differences and translational limitations
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-15: The role of lymph node dissection in upper tract urothelial carcinoma
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-16: Predictors of long-term renal function decline after radical nephroureterectomy for upper urinary tract urothelial carcinoma
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-17: Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography for lymph node staging in upper urinary tract urothelial carcinoma: a single-center retrospective study
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
Jean-Christophe Bernhard · CHU Bordeaux - University of Bordeaux
IP30-18: Loss of PKNOX2 promotes urothelial neoplastic formation as well as migration and invasion through the transcriptional inactivation of p53
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-19: Safety and efficacy of enfortumab vedotin for metastatic urothelial carcinoma in over 80 years old patients: Multi-center retrospective study in Japan
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-20: Machine Learning–Based Prediction of Progression to Radical Nephroureterectomy After Endoscopic Management of Upper Tract Urothelial Carcinoma
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-21: Clinicopathological Characteristics and Prognostic Factors of Patients with Upper Tract Urothelial Carcinoma
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
Xuanjun Guo
IP30-22: Assessing the impact of preoperative ureteroscopy on development of subsequent bladder cancer after nephroureterectomy for upper urinary tract urothelial carcinoma
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-23: Clinical, radiographic, and genomic predictors of response to neoadjuvant chemotherapy for high-risk localized upper tract urothelial carcinoma
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-24: Incorporating CKD into a Nomogram Predicting Preoperative =pT2/pN+ Upper Tract Urothelial Carcinoma: Building on the Foerster Model
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-25: In Medio Stat Virtus: Exploring the Potential of the Pulsed Tm:YAG Laser in the Endoscopic Management of UTUC
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-26: Ureteral stricture and subsequent intervention after mitomycin treatment for upper tract urothelial carcinoma: A retrospective TriNetX cohort study
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
IP30-27: Accuracy of Ureteroscopic Biopsy for Upper Tract Urothelial Cancer is Improved with the Addition of Microbiopsy
Saturday, May 16, 2026 7:00 AM to 9:00 AM
147B
